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Abstract A series of novel 1,3,4-oxadiazole derivatives (OSD, OCOD, ONOD, OPD, COD,
PMOD, and PCOD) were synthesized and characterized. Their structures were conﬁrmed on the
basis of IR, NMR and mass spectroscopy and molecular weights were found in the range
300–325 g/mol. Cancerous cell lines (MCF-7, HepG2) and non-cancerous cell lines (Chang liver
cells) were treated with these compounds for 48 h, which caused dose dependent decrease in the cell
viability. From the seven derivatives, OSD was found to be most potent with IC50 value close to
50 lM on all tested cell lines. Hence, this compound was selected for mechanistic study on
HepG2 cell lines. Fluorescent cell staining and DNA fragmentation study of 50 lM OSD on
HepG2 cells, showed events marked by apoptosis such as nuclear fragmentation, cytoplasm shrink-
age and DNA damage. Further, the cells with same treatment were quantiﬁed for apoptosis using
annexin V-PI ﬂow cytometric technique. The percentage of apoptotic cells was signiﬁcantly higher
(p< 0.05) after OSD treatment compared to control cells. OSD induced a signiﬁcant increase
Abbreviations: IC50, cytotoxic concentration which kills 50% cells; DMEM, Dulbecco’s Modiﬁed Eagle’s Medium; FBS, fetal bovine serum; MTT,
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenol tetrazolium bromide; OCOD, 1-(2-(2-chlorophenyl)-5-(pyridin-4-yl)-1,3,4-oxadiazol-3(2H)-yl) ethanone;
ONOD, 1-(2-(2-nitrophenyl)-5-(pyridin-4-yl)-1,3,4-oxadiazol-3(2H)-yl) ethanone; OSD, 2-(3-acetyl-5-(pyridin-4-yl)-2,3-dihydro-1,3,4-oxadiazol-2-yl)
phenyl acetate; PBS, phosphate buffer saline; PCR, polymerase chain reaction; SDS, sodium dodecyl sulfate; TBST, tris buffered saline-tween-20
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(p< 0.05) in the expression of the tumor suppressor p53 in HepG2 cells. The constitutive expres-
sion of anti-apoptotic protein Bcl-2 signiﬁcantly decreased (p< 0.05) after treatment, while the
expression of proapoptotic protein Bax signiﬁcantly increased (p< 0.05). The change in Bax to
Bcl-2 ratio suggested involvement of Bcl-2 family in induction of apoptosis. Furthermore, the levels
of caspase-9 and caspase-3 were signiﬁcantly (p< 0.05) up regulated in HepG2 cells after OSD
treatment. The data suggest that 1,3,4-oxadiazole derivatives induce apoptosis mediated by intrinsic
pathway of apoptosis. The ﬁndings strengthen the potential of the 1,3,4-oxadiazole scaffold OSD,
as an agent with chemotherapeutic and cytostatic activity in human hepatocellular carcinoma
in vitro.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Cell death is an important process in tissue development and
homeostasis. Cell death can be through various processes such
as apoptosis, necrosis, autophagy and corniﬁcation. This
depends on the morphological appearance, enzymological cri-
teria and functional aspects of the cell (Kroemer et al., 2005).
The term apoptosis, synonymously used for ‘‘programmed cell
death’’, was coined by Kerr et al. Loss of apoptosis is consid-
ered as one of the hallmarks in cancer (Hanahan and
Weinberg, 2000). Kerr et al. described massive apoptosis in
hormone-dependent tumor following hormone withdrawal.
This raised the possibility that apoptosis serves as a barrier
to cancer (Uren and Vaux, 1996).
Apoptosis is characterized by typical morphological events
such as cytoplasm shrinkage, plasma membrane blebbing,
fragmentation of DNA and phagocytosis by neighboring cells
(Trump et al., 1997). In cancer research, apoptotic pathways
have been well studied. Caspases and cysteine aspartate-
speciﬁc proteases are important players during cell death by
apoptosis. Dismantling of cells in apoptosis is executed by cas-
pases (Nicholson, 1999). Activation of caspases is triggered via
two important pathways, extrinsic and intrinsic. The extrinsic
pathway of apoptosis is mediated by binding of appropriate
ligands such as TNF-a and FAS to their receptors. In intrinsic
pathway mitochondrion is the central organelle, which is con-
trolled by pro- and anti-apoptotic proteins. This pathway is
characterized by release of cytochrome C from the mitochon-
drial inner membrane into the cytosol. This event is tightly
synchronized by pro- and anti-apoptotic members of the Bcl-
2 family proteins. Once released into the cytosol, cytochrome
C activates cascade of caspases, which eventually leads to cell
death. Improved knowledge of these proteins and their mech-
anism at molecular level has resulted in the discovery of new
drugs targeting apoptosis. Alteration of apoptosis by targeting
pro- and anti-apoptotic proteins may be a signiﬁcant way of
treating cancer (Alam, 2003).
1,3,4-Oxadiazoles are a class of heterocyclic compounds
with broad-spectrum biological activities. Compounds bearing
1,3,4-oxadiazole nucleus are known to exhibit anticancer activ-
ity (Abu-Zaied et al., 2011). Although work on pharmacolog-
ical activities of various substituted 1,3,4-oxadiazole
derivatives has been studied well, very few studies have inves-
tigated the molecular mechanism involved in apoptotic
activity of these compounds (Aboraia et al., 2006; Ouyang
et al., 2006).
In this study, anticancer effects of a new series of 1,3,4-
oxadiazole derivatives on cultured HepG2 human hepatocellu-
lar carcinoma cells were investigated, owing to their potential
clinical application and attractive biological activities. The
results demonstrated that 1,3,4-oxadiazole derivatives induce
considerable death in the HepG2 cells with the dying cells
exhibiting the biochemical features of apoptosis. The mecha-
nism by which these derivatives reduced proliferation of
human hepatocellular carcinoma cells was also explored by
ﬂow cytometry.
2. Materials and methods
2.1. Synthesis of 2, 5-disubstituted-1, 3, 4-oxadiazoles
Isonicotinic acid hydrazide (Isoniazid, 0.03 M) and ring
substituted aromatic aldehyde (0.03 M) were dissolved in
25 mL of methanol and reﬂuxed for 30 min in the presence
of a few drops of glacial acetic acid. The product separated
(Schiff base) was ﬁltered and recrystallized from ethanol
(yield 85–90%). The Schiff base was heated over reﬂux
with acetic anhydride for 5 h. The reaction mixture was
poured onto ice and stirred for 30 min when the 1,3,4-
oxadiazole separated. It was ﬁltered, washed, dried and
recrystallized. The seven 1,3,4-oxadiazole derivatives
synthesized in the present study were coded OSD,
OCOD, ONOD, OPD, COD, PMOD, and PCOD
(Durgashivaprasad et al., 2014, 2015). The structures were
conﬁrmed on the basis of IR, NMR and mass spec-
troscopy. The synthetic steps for the preparation of three
derivatives are given in Fig. 1.
2.1.1. Analytical data for the three compounds (Table 1)
1-[2-(2-Chlorophenyl)-5-(pyridin-4-yl)-1,3,4-oxadiazol-3-(2H)-yl]
ethanone (OCOD): MP 82 C, Yield 60%, IR (KBr)
3022 cm1 (Aromatic), 1660 cm1 (NACOCH3), 1267 cm
1
(ACAOACA), 713 cm1 (ArACl) NMR (DMSO-d6) d 2.33
(s, 3H, NACOCH3), 6.9 (s, 1H, AOACHAN(COCH3), 7.2–
7.7 (d, 6H, ArAH), 8.8 (2H, ACHANACHA). [M]+ 302.
2-[3-Acetyl-5-(pyridin-4-yl)-2,3-dihydro-1,3,4-oxadiazol-2-
yl]phenyl acetate (OSD): MP 160 C, Yield 64%, IR (KBr)
3045 cm1 (Aromatic), 1768 cm1 (OCOCH3), 1670 cm
1
(NACOCH3), 1271 cm
1 (CAOAC, asymmetric). NMR
(DMSO-d6) d 2.1(3H, NACOCH3), 2.21 (3H, OACOCH3),
3.16 (1H), 7.2–7.7 (4H, aromatic), 8.7 (4H, pyridine) [M]+ 325.
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1-[2-(2-Nitrophenyl)-5-(pyridin-4-yl)-1,3,4-oxadiazol-3(2
H)-yl]ethanone (ONOD): MP 165 C, Yield 70%, IR (KBr)
3060 cm1 (Aromatic), 1670 cm1 (NACOCH3), 1530
and 1444 cm1 (ANO2), NMR (DMSO, d6) d 2.3 (3H,
ACOCH3), 7.07 (1H, OACHANACOCH3), 7.3–7.6 (6H,
ArAH), 8.6 (2H, ACHANACHA), [M]+ 312.
1-(5-(Pyridin-4-yl)-2-styryl-1,3,4-oxadiazol-3(2H)-yl)
ethanone (COD):MP 65 C, Yield: 67%, IR (KBr) 1757 cm1
(ACOCH3), 1676 cm
1 (ACH‚CHA), 1242 cm1
(ACAOACA, asymmetric), 1062 cm1 (ACAOAC, symmet-
ric), 3470–3030 cm1 (AAr), 2920 and 2850 cm1 (ACH2A
of Ar), 1630–1430 cm1 (AC‚N, pyridine).
4-(3-Acetyl-5-pyridin-4-yl)-2,3-dihydro-1,3,4-oxadiazol-2-yl)
phenyl acetate (OPD): MP 140 C, Yield 64%, IR (KBr)
1751 cm1 (AOCOCH3), 1680 cm
1 (ACOCH3), 1265 cm
1,
(ACAOACA, asymmetric), 1020 cm1 (ACAOACA,
symmetric), 2933–2850 cm1 (CH2AAr), 3070 cm
1 (Ar),
1598–1411 cm1 (AC‚N, pyridine) NMR (DMSO-d6) d 2.26
(3H, s, ACOCH3), 2.28 (3H, s, AOCOCH3), 7.24 (1H, s,
OACHANA), 7.19–7.57 (4H, m, ArAH), 7.71–8.80 (4H, m,
ArAH of pyridine); [M]+ 325.
1-(2-(4-Chlorophenyl)-5-(pyridin-4-yl)-1,3,4-oxadiazol-3
(2H)-yl) ethanone (PCOD):MP 120 C, Yield: 71%, IR (KBr)
1660 cm1 (ACOCH3), 713 cm
1 (ArACl), 1267 cm1
(ACAOAC, asymmetric), 1035 cm1 (ACAOAC, symmetric),
2958 and 2848 cm1 (ACH2A, Ar), 3313 cm
1 (AAr),
1442 cm1 (AC‚N, pyridine); [M+1]+ 302.08.
1-(5-(Pyridin-4-yl)-2-p-tolyl-1,3,4-oxadiazol-3(2H)-yl)
ethanone PMOD:MP 80 C, Yield: 64%, IR (KBr) 1317 cm1
(ACH3), 1670 cm
1 (ACOCH3), 1255 cm
1 (ACAOAC,
asymmetric), 1022 cm1 (ACAOAC, symmetric), 3441 cm1
(AAr), 2930 and 2835 cm1 (ACH2A, of Ar), 1612–
1411 cm1 (AC‚N, pyridine); [M+1]+ 282.17.
2.2. Chemicals
FBS, DMEM, antibiotic–antimycotic, PCR kits, MTT reagent,
sulforhodamine B dye (SRB), agarose, and other chemicals for
western blotting were purchased from Sigma–Aldrich, St Louis,
USA. Primary rabbit polyclonal antibodies against Bax, Bcl-2,
p53, cytochromeC, caspase-9, caspase-3 and secondary antibody
(goat anti-rabbit IgG-HRP) were purchased from Santa Cruz
Biotechnology, Inc., USA. Primers for reverse transcriptase-
PCR were purchased from Bioserve Technologies Pvt. Ltd.,
Hyderabad, India. HEPES sodium salt buffer solution, dithio-
threitol (DTT), SDS, bovine serum albumin (BSA), and common
laboratory chemicals were purchased from Himedia Lab Pvt.
Ltd., Mumbai, India. All other chemicals were of highest grade
and were procured from either Sigma or Merck.
2.3. Cell culture and cell viability assay
Human hepatocellular carcinoma cells HepG2 and human
breast cancer cells MCF-7, were used in the study. Cell lines
were purchased from NCCS Pune, India. HepG2 and MCF-
7 cells were grown in DMEM supplemented with 10%
heat-inactivated FBS, 1% antibiotic–antimycotic solution in
a humidiﬁed incubator (5% CO2 in air at 37 C). Cells
(2 · 105 cells/ml) were cultured in T25 ﬂasks.
2.3.1. Cell viability by MTT and SRB assay
HepG2 and MCF-7 cells were seeded for 24 h in 96-well plates
at 1 · 104 cells/well. The compounds were added in quadrupli-
cates at different concentrations and incubated for 48 h. For
MTT assay (Denizot and Lang, 1986), 50 lL of MTT reagent
Figure 1 Chemical structures and synthetic steps involved in
preparation of derivatives of 2,5-disubstituted-1,3,4-oxadiazoles.







OCOD C15H15ClN3O2 301.06 82
OSD C17H11N3O4 325 160
ONOD C15H12N4O4 312.28 165
COD C17H15N3O2 293.32 65
OPD C17H11N3O4 325 140
PCOD C15H12ClN3O2 301.06 120
PMOD C16H15N3O2 281.31 80
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(2 mg/ml in PBS) was added and incubated for 4 h at 37 C.
The purple colored formazan crystals were then dissolved in
50 lL isopropanol for 15 min with shaking. The absorbance
was measured at 540 nm using the microplate reader (Bio-
Tek, ELX-800 MS). For Sulforhodamine B (SRB) assay
(Skehan et al., 1990), cells were ﬁxed by 50% trichloroacetic
acid (TCA). Fixed cells were incubated with SRB (0.4% in
TCA) dye for 30 min. Dye was solubilized using 10 mM tris
base solution. Absorbance was measured at 540 nm and IC50
was calculated. Cisplatin, a standard anticancer drug was used
as positive control.
2.4. Nuclear staining
Condensation of chromatin is a dramatic event in cells under-
going apoptotic death (Trump et al., 1997). Nuclear staining
was performed as per the standard protocol (Kumar et al.,
2012b). Brieﬂy, 1 · 105 HepG2 cells per mL were grown in
12-well plates and subjected to the treatment with OSD at
50 lM concentration or 12 lM cisplatin (both below IC50).
After ﬁxing, the cells were stained with acridine orange
(0.1 mg/ml) and Hoescht 33342 (10 lg/ml), and observed under
ﬂuorescence microscope. When acridine orange intercalates
into double stranded DNA it emits green ﬂuorescence upon
excitation at 480–490 nm. Hoescht 33342 dye is excited by
ultraviolet light at around 350 nm and emits blue ﬂuorescence.
2.5. DNA fragmentation assay
Important signature of apoptosis is the cleavage of nuclear
DNA into small-sized fragments (Basnakian and James,
1994). 1 · 105 HepG2 cells per mL DMEM were grown in
T25 ﬂasks for 24 h and treated with either 50 lM OSD or
12 lM cisplatin. After 24 h of drug incubation, the genomic
DNA was extracted from cells with phenol–chloroform extrac-
tion procedure, resolved on 1.5% agarose gel containing
0.5 lg/ml ethidium bromide (Kumar et al., 2012a).
Fragmentation pattern was observed under UV light with
the help of Alpha Innotech, Inc gel doc system.
2.6. Quantitative FITC-annexin V/PI bivariate ﬂow cytometry
Apoptosis determination was done using Sigma’s annexin
V-FITC apoptosis detection kit, following the manufacturer’s
protocol. Brieﬂy, 1 · 106 HepG2 cells/ml DMEMwere cultured
and treated with OSD at 50 lM and cisplatin at 12 lM
concentrations. After 24 h of incubation, cells were removed
with scraper, centrifuged andwashed with PBS twice. Cells were
suspended in 1X binding buffer (10 mMHEPES/NaOH, pH 7.5
containing 0.14 M NaCl and 2.5 mM CaCl2) and subjected to
5 ll of annexin V-FITC and 10 ll of propidium iodide
stain in binding buffer at room temperature for 10 min in
the dark (Jain et al., 2013). Apoptotic cells were analyzed
by ﬂuorescence-activated cell sorting using Cell Quest Pro
software.
2.7. Reverse transcriptase-PCR analysis
50 lM OSD and 12 lM cisplatin were incubated for 24 h over
HepG2 cells and the RNA was isolated using trizol extraction
procedure (Kumar et al., 2012b). The cDNA (complementary
DNA) was synthesized from isolated RNA and ampliﬁed using
primers for Bcl-2, p53, Bax, (Table 3), using Invitrogen’s KOD
hot start DNA polymerase as per manufacture’s protocol.
PCR product was visualized on 1.5% agarose gel using ethid-
ium bromide and optical densities of DNA bands computed by
Alpha Innotech software, USA (Jagani et al., 2013; Mullis
et al., 1986). Bands were subjected to statistical analysis.
2.8. Western blot analysis
1 · 105 HepG2 cells/ml DMEM were cultured in T25 ﬂasks for
24 h and incubated with 50 lM OSD and 12 lM cisplatin for
another 24 h. After exposure, the total proteins were extracted
from cells using Invitrogen’s trizol reagent as per the manufac-
turer’s protocol. The extracted proteins were quantiﬁed by
Lowry method after solubilizing the proteins in 0.1% SDS
solution. These proteins were then resolved on 15% SDS poly-
acrylamide gel and transferred onto a nitrocellulose mem-
brane. The membrane was blocked with casein (1%) in Tris
buffer saline and incubated overnight at 4 C with antibodies
for Bcl-2, p53, Bax, caspase-9 and caspase-3. b-Actin was used
as marker for western blotting. At the end of incubation, the
membrane was washed with TBST and incubated with the sec-
ondary antibody conjugated with horseradish peroxidase
(HRP) for 4 h at 4 C. The proteins were detected by using
TMB/H2O2 as a chromogenic substrate. Bands were subjected
to statistical analysis.
2.9. Cytochrome C in mitochondrial fraction
For the detection of cytochrome C in mitochondrial fraction,
after 24 h treatment, mitochondria were isolated from
HepG2 cells by sucrose density gradient centrifugation
(Arnoult et al., 2002; Eskes et al., 1998). Mitochondrial frac-
tion was assessed by western blotting for the presence of
Cytochrome C, as described in Section 2.8.
2.10. Statistical analysis
Data are represented as the mean ± SEM of the speciﬁed
number of experiments. Statistical analysis of the data was
done by one-way ANOVA followed by Tukey’s post hoc test
Table 2 IC50 values (lM) of compounds on HepG2, MCF-7










1 OSD 52.71 ± 3.54 15.47 ± 0.79 42.38 ± 2.34
2 OCOD 82.73 ± 3.78 94.19 ± 2.45 65.17 ± 1.57
3 ONOD 114.71 ± 5.11 85.69 ± 1.81 122.20 ± 1.81
4 OPD 395.09 ± 5.65 230.27 ± 1.02 601.79 ± 4.91
5 COD 163.70 ± 4.90 154.15 ± 3.41 297.98 ± 4.64
6 PMOD 529.03 ± 7.22 311.23 ± 0.98 640.46 ± 3.01
7 PCOD 499.13 ± 3.22 289.54 ± 1.73 476.605 ± 3.27
8 Cisplatin 11.09 ± 0.59 10.53 ± 0.56 81.67 ± 2.33
All the values are mean ± SEM of four determinations in triplicate
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(GraphPad Prism Version 5.02, Instat Software, La Jolla, CA,
USA). A value of p< 0.05 was considered signiﬁcant.
3. Results
3.1. Effects on cell viability
The compounds decreased HepG2 and MCF-7 cells viability in
a concentration dependent manner. The IC50 value of OSD
was signiﬁcantly lower (p< 0.05) than OCOD, ONOD.
Therefore, for further mechanistic studies, OSD was selected
as the leading candidate and additionally, a concentration
below IC50 was selected for the compound OSD (50 lM) as
well as cisplatin (12 lM) (Table 2).
3.2. OSD induced nuclear condensation
Nuclear staining of OSD-treated HepG2 cells with acridine
orange (AO) and Hoescht 33342 (Fig. 2) indicated typical
apoptotic morphology like nuclear fragmentation (NF) and
cytoplasm shrinkage (CS). In contrast, the untreated HepG2
cells showed intact nuclear architecture. The morphological
changes induced by OSD and cisplatin were similar and
comparable.
3.3. OSD induced fragmentation of DNA
The agarose gel electrophoresis of the compound OSD-treated
DNA showed fragmentation with a ladder-like pattern. The
results of cisplatin were similar (Fig. 2). The control DNA
was intact.
3.4. Apoptosis versus necrosis
The percentage of apoptotic cells in the OSD-treated cells was
signiﬁcantly higher (ap< 0.05) compared to cisplatin. The
cells in the lower right (LR) quadrant of the histogram
(Fig. 2) represent the number of early apoptotic cells stained
with annexin V-FITC. The percentage of cells undergoing
apoptosis upon treatment with OSD was signiﬁcantly higher
(bp< 0.05) than the necrotic cells.
3.5. OSD increased p53 expression
The treatment of HepG2 cells with 50 lM OSD resulted in a
signiﬁcant increase (p< 0.05) in expression of p53 (Fig. 3A)
and basal level of p53 protein (Fig. 3A) compared to the
untreated HepG2 cells. Similar results were seen with cisplatin.
3.6. OSD altered Bax/Bcl-2 ratio
OSD and cisplatin treatment resulted in signiﬁcantly decreased
(p< 0.05) level of Bcl-2 compared to untreated cells
(Fig. 3A). The expression of Bax was signiﬁcantly higher
(p< 0.05) in OSD and cisplatin treated cells. The results indi-
cated that OSD induced apoptosis by altering Bax/Bcl-2 ratio
in HepG2 cells as compared to untreated cells.
3.7. OSD activated caspase-9, -3 and induced cytochrome C
release from the mitochondria
The expression of caspase 3 and caspase 9 was signiﬁcantly
higher (p< 0.05) in OSD-treated cells, compared to untreated
cells (Fig. 3B). OSD also produced a decrease of cytochrome
C in mitochondrial fraction of HepG2 cells compared with
untreated mitochondrial fraction (Fig. 3). The OSD treatment
seems to cause the release of cytochrome C into the cytosol.
PCR and western blot analysis of OSD-treated HepG2 cells
showed that expression of caspase-9 and caspase-3 signiﬁ-
cantly increased (p< 0.05) when compared with untreated
HepG2 cells.
4. Discussion
In the present work, 2, 5-disubstituted-1, 3, 4-oxadiazoles were
synthesized and characterized. The compounds were made by
cyclizing a schiff base. The schiff bases were made by a conden-
sation reaction involving isoniazid and seven different aldehy-
des. These aldehydes have different substitutions. Differing
substitutions could produce differences in activities as well,
which may be due to differences in physico–chemical properties
and binding to relevant biological sites. For instance, in the pre-
sent case the most active molecule is OSD, which has an acetyl
substitution in the phenyl ring at the ortho position. OSD dif-
fers from OPD in the position of the substitution. OPD also
carries an acetyl phenyl ring, but the acetylation is in the para
position. Similarly the other two active molecules, viz.,
OCOD and ONOD have a chloro and a –NO2 substitution,
respectively, at the ortho position in the phenyl ring. It seems
that ortho- substitutions on the phenyl ring confers activity,
which may be due to interactions with relevant biological sites.
The inhibitory effect of these derivatives was tested on
human hepatocellular carcinoma cells HepG2, human breast
cancer cells MCF-7 and non-tumoral Chang liver cells. The
MTT and SRB results showed antiproliferative activity of
these compounds on all three cell lines. However, out of the
seven derivatives used for screening of their cytotoxicity, only
OSD showed IC50 value close to 50 lM on all tested cell lines.
Table 3 Sequence of forward (F) and reverse (R) primers.
Primer Sequence (50–30) Annealing temperature (C)
Bcl-2 F GGAGCGTCAACAGGGAGATG 56
R GATGCCGGTTCAGGTACTCAG
Bax F CCAAGAAGCTGAGCGAGTGTCTC 56
R AGTTGCCATCAGCAAACATGTCA
p53 F CAGCTTTGAGGTTCGTGTTTGT 51
R ATGCTCTTCTTTTTTGCGGAAA
OSD activity in human hepatocellular carcinoma 5
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Hence, this compound was selected for mechanistic study on
HepG2 cell lines. The dying HepG2 cells exhibited morpholog-
ical and biochemical features that characterized apoptosis, as
shown by chromatin condensation, formation of apoptotic
bodies and DNA fragmentation (Fig. 2).
One of the main causes of tumor development is inhibition
of apoptosis. Many chemopreventive agents inhibit carcino-
genic process through induction of apoptosis (Alam, 2003).
Therefore, quantiﬁcation of apoptosis and necrosis was further
studied by ﬂow cytometry using annexin-V FITC and propid-
ium iodide dyes. Data showed that early apoptosis was
induced in HepG2 cells after OSD treatment (Fig. 2). The
results were comparable to cisplatin.
Tumor suppressor p53 protein is one of the regulators of
apoptosis (El-Deiry, 2003). To investigate the possible role of
p53 in OSD-induced apoptosis, regulation of p53 mRNA
and P53 protein levels was investigated by PCR and western
blotting, respectively. It is evident from the results that p53
mRNA level and basal level of p53 protein signiﬁcantly
increased (p< 0.05) after OSD treatment in HepG2 cells.
This suggests that apoptosis by OSD is mediated via p53 pro-
tein expression.
Both Bcl-2 and Bax are targets of tumor suppressor p53
protein. The role of Bcl-2 family proteins is well known in
apoptosis as they are important players in apoptotic cell death.
In regulation of intrinsic pathway of apoptosis Bcl-2 and Bax
protein ratio has been recognized as a key factor (Lindsay
et al., 2010). In the present study, the increase in the OSD-
induced apoptosis was associated with signiﬁcant (p< 0.05)
up regulation of protein Bax and signiﬁcant (p< 0.05) down
regulation of protein Bcl-2. Analysis of the data obtained from
reverse transcriptase PCR and western blot analysis revealed
that OSD affects the Bcl-2/Bax ratio and therefore, leads to
mitochondrial membrane disruption in HepG2 cells.
Change in Bax/Bcl-2 ratio disrupts mitochondrial
membrane and can promote the release of cytochrome C from
mitochondria into the cytosol, which in turn, activates caspase-
9 and capase-3 (Lindsay et al., 2010). Caspase-3 is one of the
Figure 2 Apoptotic studies. (A) DNA fragmentation assay. DNA extracted from HepG2 cells viewed on ethidium bromide stained gel.
DNA from untreated cells (UC), DNA from cisplatin treated cells (CP), and DNA from OSD treated cells (OSD). DNA from OSD
treated cells showed fragmentation pattern comparable to DNA from cisplatin treated cells. (B) Nuclear staining of HepG2 cells with
Acridine orange (AO)- stained in green color and Hoescht 33342- stained in blue color. Untreated HepG2 cells (UC) had intact, oval
nucleus. Arrows indicate cytoplasmic shrinkage (CS) and nuclear fragmentation (NF) in cisplatin (CP) and OSD treated cells. (C) Flow
cytometric analysis using annexin-V FITC and propidium iodide (PI). Untreated HepG2 cells (UC), cells after cisplatin treatment (CP),
and cells after OSD treatment (OSD). Lower right (LR), % early apoptotic cells (annexin-V stained cells); Upper right (UR), % late
apoptotic cells (PI and annexin-V stained cells); Lower left (LL) % live cells; Upper left (UL), % of necrotic cells (PI stained cells). The
data are represented as the mean ± SEM of three independent experiments. ap < 0.05 compared to cisplatin; bp < 0.05 compared to
necrotic cells.
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executioners of apoptosis (Nicholson, 1999). The result showed
that cytochrome C was reduced in mitochondrial fraction after
treatment of HepG2 cells with OSD and the change in Bax/Bcl-
2 ratio resulted in release of cytochrome C from the mitochon-
dria. Antibodies in this study for caspase-3 and caspase-9
expression were used against the active form of caspase-3 and
9. Thus increased expression of caspase 3 and 9 represents
upregulation of their active form. All these results indicate that
OSD induced the apoptotic-signaling pathway in HepG2 cells.
5. Conclusion
OSD exhibits its antiproliferative effect by induction of p53
mediated intrinsic pathway of apoptosis in HepG2 cells. The
ﬁndings conﬁrm the potential of the 1,3,4-oxadiazole deriva-
tive, OSD, as an agent with chemotherapeutic and cytostatic
activity in human hepatocellular carcinoma. However, further
investigation of its in vivo activity is necessary to exploit its
tumor reducing potential and toxicity proﬁle.
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